comment on "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease"

被引:0
|
作者
Costa, Marco [1 ]
机构
[1] Corpo Redatorial Revista Portuguesa Cardiol, Lisbon, Portugal
关键词
PCSK9;
D O I
10.1016/j.repc.2017.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:485 / 486
页数:2
相关论文
共 50 条
  • [31] Defining outcomes in older patients with cardiovascular disease
    Pashos, CL
    DRUGS & AGING, 1997, 10 (04) : 243 - 248
  • [32] Marital Status and Outcomes in Patients With Cardiovascular Disease
    Schultz, William M.
    Hayek, Salim S.
    Tahhan, Ayman Samman
    Ko, Yi-An
    Sandesara, Pratik
    Awad, Mosaab
    Mohammed, Kareem H.
    Patel, Keyur
    Yuan, Michael
    Zheng, Shuai
    Topel, Matthew L.
    Hartsfield, Joy
    Bhimani, Ravila
    Varghese, Tina
    Kim, Jonathan H.
    Shaw, Leslee
    Wilson, Peter
    Vaccarino, Viola
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
  • [33] Defining Outcomes in Older Patients with Cardiovascular Disease
    Chris L. Pashos
    Drugs & Aging, 1997, 10 : 243 - 248
  • [34] Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction A Prespecified Secondary Analysis From the FOURIER Trial
    Gencer, Baris
    Mach, Francois
    Murphy, Sabina A.
    De Ferrari, Gaetano M.
    Huber, Kurt
    Lewis, Basil S.
    Ferreira, Jorge
    Kurtz, Christopher E.
    Wang, Huei
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc S.
    Giugliano, Robert P.
    JAMA CARDIOLOGY, 2020, 5 (08) : 952 - 957
  • [35] Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
    Xie, Wenwen
    Song, Yinyin
    Qin, Xiaomei
    Jin, Pengfei
    ADVANCES IN THERAPY, 2023, 40 (02) : 489 - 503
  • [36] COST-EFFECTIVENESS OF EVOLOCUMAB VERSUS STANDARD THERAPY FOR THE TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH CARDIOVASCULAR DISEASE IN QATAR
    AlMukdad, S.
    Kaddoura, R.
    Arabi, A. R.
    AlMaraghi, F.
    Al Yafei, Al-Saadi S.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2022, 25 (07) : S389 - S389
  • [37] Comment on: Cardiovascular Outcomes of Patients Referred to Home Based Cardiac Rehabilitation
    Mahfooz, Kamran
    Najeed, Syed
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (10)
  • [38] Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
    Murphy, Sabina A.
    Pedersen, Terje R.
    Gaciong, Zbigniew A.
    Ceska, Richard
    Ezhov, Maiat, V
    Connolly, Derek L.
    Jukema, J. Wouter
    Toth, Kalman
    Tikkanen, Matti J.
    Im, Kyungah
    Wiviott, Stephen D.
    Kurtz, Christopher E.
    Honarpour, Narimon
    Giugliano, Robert R.
    Keech, Anthony C.
    Sever, Peter S.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2019, 4 (07) : 613 - 619
  • [39] Comment on "Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease"
    Coban, Erkan
    ATHEROSCLEROSIS, 2019, 280 : 194 - 194
  • [40] Living in Food Deserts and Adverse Cardiovascular Outcomes in Patients With Cardiovascular Disease
    Kelli, Heval M.
    Kim, Jeong Hwan
    Tahhan, Ayman Samman
    Liu, Chang
    Ko, Yi-An
    Hammadah, Muhammad
    Sullivan, Samaah
    Sandesara, Pratik
    Alkhoder, Ayman A.
    Choudhary, Fahad K.
    Gafeer, M. Mazen
    Patel, Keyur
    Qadir, Saqib
    Lewis, Tene T.
    Vaccarino, Viola
    Sperling, Laurence S.
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (04):